Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.

Autor: Kamei N; Laboratory of Drug Delivery Systems, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Hyogo 650-8586, Japan., Bech Nielsen EJ; Laboratory of Drug Delivery Systems, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Hyogo 650-8586, Japan; Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Måløv, Denmark; Novozymes A/S, DK-2880 Bagsvaerd, Denmark., Nakakubo T; Laboratory of Drug Delivery Systems, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Hyogo 650-8586, Japan., Aoyama Y; Laboratory of Drug Delivery Systems, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Hyogo 650-8586, Japan., Rahbek UL; Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Måløv, Denmark., Pedersen BL; Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Måløv, Denmark., Takeda-Morishita M; Laboratory of Drug Delivery Systems, Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Hyogo 650-8586, Japan. Electronic address: mmtakeda@pharm.kobegakuin.ac.jp.

Publikováno v: Journal of pharmaceutical sciences [J Pharm Sci] 2016 Feb; Vol. 105 (2), pp. 747-753.